ZEB2 has a prominent role in driving epithelial to mesenchymal transition (EMT) in development, fibrosis and in cancer, where high levels correlate with many types of invasive cancer, including the most malignant form of breast cancer; the triple negative basal- like carcinoma [1, 8, 9]. This evidence concerns the gene ZEB2 and breast cancer.